303 related articles for article (PubMed ID: 16819400)
1. "Let there be bile"--understanding hepatic injury in cholestasis.
Sokol RJ; Devereaux M; Dahl R; Gumpricht E
J Pediatr Gastroenterol Nutr; 2006 Jul; 43 Suppl 1():S4-9. PubMed ID: 16819400
[TBL] [Abstract][Full Text] [Related]
2. Beta-carotene prevents bile acid-induced cytotoxicity in the rat hepatocyte: Evidence for an antioxidant and anti-apoptotic role of beta-carotene in vitro.
Gumpricht E; Dahl R; Devereaux MW; Sokol RJ
Pediatr Res; 2004 May; 55(5):814-21. PubMed ID: 14764912
[TBL] [Abstract][Full Text] [Related]
3. [The bile acids as an example of patogens destructive hepatocytes in alcoholic liver injury].
Ogłodek E; Augustyńska B; Araszkiewicz A; Moś D
Pol Merkur Lekarski; 2009 Oct; 27(160):346-8. PubMed ID: 19928668
[TBL] [Abstract][Full Text] [Related]
4. Endogenous opioids modulate hepatocyte apoptosis in a rat model of chronic cholestasis: the role of oxidative stress.
Payabvash S; Kiumehr S; Nezami BG; Zandieh A; Anvari P; Tavangar SM; Dehpour AR
Liver Int; 2007 May; 27(4):538-47. PubMed ID: 17403194
[TBL] [Abstract][Full Text] [Related]
5. Antinecrotic and antiapoptotic effects of hepatocyte growth factor on cholestatic hepatitis in a mouse model of bile-obstructive diseases.
Li Z; Mizuno S; Nakamura T
Am J Physiol Gastrointest Liver Physiol; 2007 Feb; 292(2):G639-46. PubMed ID: 17068118
[TBL] [Abstract][Full Text] [Related]
6. CHOP deficiency attenuates cholestasis-induced liver fibrosis by reduction of hepatocyte injury.
Tamaki N; Hatano E; Taura K; Tada M; Kodama Y; Nitta T; Iwaisako K; Seo S; Nakajima A; Ikai I; Uemoto S
Am J Physiol Gastrointest Liver Physiol; 2008 Feb; 294(2):G498-505. PubMed ID: 18174271
[TBL] [Abstract][Full Text] [Related]
7. Increased susceptibility of fat-laden Zucker-rat hepatocytes to bile acid-induced oncotic necrosis: an in vitro model of steatocholestasis.
Kobak GE; Dahl R; Devereaux MW; Gumpricht E; Traber M; Doctor RB; Sokol RJ
J Lab Clin Med; 2005 May; 145(5):247-62. PubMed ID: 15902097
[TBL] [Abstract][Full Text] [Related]
8. Oxidative stress and the pathogenesis of cholestasis.
Copple BL; Jaeschke H; Klaassen CD
Semin Liver Dis; 2010 May; 30(2):195-204. PubMed ID: 20422501
[TBL] [Abstract][Full Text] [Related]
9. The role of mitochondria in cholestatic liver injury.
Tiao MM; Lin TK; Wang PW; Chen JB; Liou CW
Chang Gung Med J; 2009; 32(4):346-53. PubMed ID: 19664341
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of bile-salt-induced hepatocyte apoptosis by the antioxidant lazaroid U83836E.
Patel T; Gores GJ
Toxicol Appl Pharmacol; 1997 Jan; 142(1):116-22. PubMed ID: 9007040
[TBL] [Abstract][Full Text] [Related]
11. Glycyrrhizic acid modulates t-BHP induced apoptosis in primary rat hepatocytes.
Tripathi M; Singh BK; Kakkar P
Food Chem Toxicol; 2009 Feb; 47(2):339-47. PubMed ID: 19084568
[TBL] [Abstract][Full Text] [Related]
12. Bile acid regulation of hepatic physiology: IV. Bile acids and death receptors.
Higuchi H; Gores GJ
Am J Physiol Gastrointest Liver Physiol; 2003 May; 284(5):G734-8. PubMed ID: 12684208
[TBL] [Abstract][Full Text] [Related]
13. Mitochondrial glutathione: hepatocellular survival-death switch.
Garcia-Ruiz C; Fernandez-Checa JC
J Gastroenterol Hepatol; 2006 Oct; 21 Suppl 3():S3-6. PubMed ID: 16958667
[TBL] [Abstract][Full Text] [Related]
14. c-Met confers protection against chronic liver tissue damage and fibrosis progression after bile duct ligation in mice.
Giebeler A; Boekschoten MV; Klein C; Borowiak M; Birchmeier C; Gassler N; Wasmuth HE; Müller M; Trautwein C; Streetz KL
Gastroenterology; 2009 Jul; 137(1):297-308, 308.e1-4. PubMed ID: 19208365
[TBL] [Abstract][Full Text] [Related]
15. Up-regulation of nerve growth factor in cholestatic livers and its hepatoprotective role against oxidative stress.
Tsai MS; Lin YC; Sun CK; Huang SC; Lee PH; Kao YH
PLoS One; 2014; 9(11):e112113. PubMed ID: 25397406
[TBL] [Abstract][Full Text] [Related]
16. Mitochondria protection as a mechanism underlying the hepatoprotective effects of glycine in cholestatic mice.
Heidari R; Ghanbarinejad V; Mohammadi H; Ahmadi A; Ommati MM; Abdoli N; Aghaei F; Esfandiari A; Azarpira N; Niknahad H
Biomed Pharmacother; 2018 Jan; 97():1086-1095. PubMed ID: 29136945
[TBL] [Abstract][Full Text] [Related]
17. Subcutaneous vitamin E ameliorates liver injury in an in vivo model of steatocholestasis.
Soden JS; Devereaux MW; Haas JE; Gumpricht E; Dahl R; Gralla J; Traber MG; Sokol RJ
Hepatology; 2007 Aug; 46(2):485-95. PubMed ID: 17659596
[TBL] [Abstract][Full Text] [Related]
18. Bile salts and cholestasis.
Maillette de Buy Wenniger L; Beuers U
Dig Liver Dis; 2010 Jun; 42(6):409-18. PubMed ID: 20434968
[TBL] [Abstract][Full Text] [Related]
19. Mitochondrial free cholesterol loading sensitizes to TNF- and Fas-mediated steatohepatitis.
Marí M; Caballero F; Colell A; Morales A; Caballeria J; Fernandez A; Enrich C; Fernandez-Checa JC; García-Ruiz C
Cell Metab; 2006 Sep; 4(3):185-98. PubMed ID: 16950136
[TBL] [Abstract][Full Text] [Related]
20. Bile acid-mediated thrombospondin-1 induction in hepatocytes leads to transforming growth factor-beta-dependent hepatic stellate cell activation.
Myung SJ; Yoon JH; Gwak GY; Kim W; Yang JI; Lee SH; Jang JJ; Lee HS
Biochem Biophys Res Commun; 2007 Feb; 353(4):1091-6. PubMed ID: 17204245
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
